Ani Pharmaceuticals (ANIP) Change in Taxes (2014 - 2026)

Ani Pharmaceuticals has disclosed Change in Taxes across 13 years of filings, most recently posting -$1.8 million for Q2 2026.

• In Q2 2026, Change in Taxes rose 83.75% year-over-year to -$1.8 million; the TTM figure through Jun 2026 stood at $241000.0 (down 96.09% YoY), while the FY2025 annual figure was -$15.5 million, down 997.6% from the prior year.
• Change in Taxes came in at -$1.8 million for Q2 2026 at Ani Pharmaceuticals, down from $14.1 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $14.1 million in Q1 2026 to a low of -$14.3 million in Q2 2024.
• Average Change in Taxes over 5 years is $400111.1, with a median of $30500.0 recorded in 2022.
• Year-over-year, Change in Taxes soared 15538.78% in 2023 and sank 3942.21% in 2024.
• Over 5 years, Change in Taxes stood at -$49000.0 in 2022, then soared by 15538.78% to $7.6 million in 2023, then jumped by 69.9% to $12.9 million in 2024, then plunged by 96.33% to $472000.0 in 2025, then tumbled by 475.0% to -$1.8 million in 2026.
• Per Business Quant data, the three most recent Change in Taxes figures were -$1.8 million in Q2 2026, $14.1 million in Q1 2026, and $472000.0 in Q4 2025.